Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment

Table 2 Laboratory findings at onset of acute liver failure

WBC	5800/μL	BUN	5.0 mg/dL	ANA	× 160
Hb	12.2 g/dL	Creatinine	0.7 mg/dL	ASMA	Negative
Plt	290 × 103 /μL	Uric acid	2.8 mg/dL	LKM-1	Positive
PT	41.4%	Na	138 mEq/L	AMA	Negative
APTT	44.4 sec	K	3.9 mEq/L	IgG	2436mg/dL
		Cl	105 mEq/L	IgA	175 mg/dL
		Total cholesterol	175 mg/dL	IgM	280 mg/dL
AST	311 IU/L	Triglyceride	67 mg/dL
ALT	280 IU/L	Glucose	127 mg/dL
LDH	245 IU/L	CRP	0.2 mg/dL	HCV-RNA	13 kIU/l
ALP	571 IU/L			HBs-Ag	Negative
γ-GTP	108 IU/L	Tyrosin	262 μmol/L	HBs-Ab	Negative
ChE	124 IU/L	BCAA	313 μmol/L	HBc-Ab IgM	Negative
Total bilirubin	5.5 mg/dL			HAV	Negative
Direct bilirubin	3.3 mg/dL	TSH	0.499 μIU/mL	EBV	Negative
Total protein	7.4 g/dL	T3	1.66 pg/mL	HSV	Negative
Albumin	3.1 g/dL	T4	0.55 ng/dL	CMV	Negative

APTT: activated partial thromboplastin time; CRP: C-reactive protein; BCAA: branched-chain amino acid; TSH: thyroid-stimulating hormone; LKM-1: antibody to microsomes type 1; HBc-Ab: hepatitis B virus core antibody; HAV: hepatitis A virus; EBV: Epstein-Barr virus; HSV: herpes simplex virus; CMV: cytomegalovirus.